Oncotype DX® Cost-effectiveness of Oncotype DX® to target chemotherapy use in lymph-node-negative, oestrogen-receptor-positive, early-stage breast cancer in Ireland. Pharmacoeconomic Evaluation Commenced Completed Outcome 24/05/2011 22/07/2011 Reimbursement not recommended at the submitted price 3rd October 2011 Following a price revision the NCPE now consider Oncotype DX a cost-effective therapy to target […]
Colorectal Cancer Screening programme
Colorectal Cancer Screening programme Health Technology Assessment (HTA) of population-based colorectal cancer screening programme in Ireland This HTA was prepared by the National Cancer Registry Ireland, the National Centre for Pharmacoeconomics, the School for Health & Related Research, Sheffield University and Dublin City University. It is available on the HIQA […]
Universal Infant Hepatitis B Vaccination programme
Universal Infant Hepatitis B Vaccination programme Cost effectiveness analysis of a universal infant hepatitis B vaccination programme in Ireland In October 2006, the National Centre for Pharmacoeconomics conducted an economic evaluation of the cost-effectiveness of a universal hepatitis B vaccination programme, for the Health Protection Surveillance Centre/National Immunisation Advisory Committee. […]
Rotavirus Vaccine
Rotavirus Vaccine Cost effectiveness analysis of a universal infant rotavirus vaccination programme in Ireland. In January 2010, the National Centre for Pharmacoeconomics completed the evaluation of the cost-effectiveness of a universal rotavirus vaccination programme in Ireland, on behalf of the National Immunisation Advisory Committee (NIAC). A summary of the main […]
Pneumococcal conjugate vaccine
Pneumococcal conjugate vaccine Cost effectiveness analysis of a universal infant pneumococcal conjugate vaccination programme in Ireland. In March 2007, the National Centre for Pharmacoeconomics evaluated the cost-effectiveness of a universal pneumococcal conjugate vaccination programme in Ireland. A summary of the main findings are available in the attached document. Pneumococcal Conjugate […]
Human Papillomavirus Vaccine
Human Papillomavirus Vaccine Health Technology Assessment on the role of vaccination against human papillomavirus in reducing the risk of cervical cancer in Ireland. In February 2008, the NCPE completed the HTA of the human papillomavirus (HPV) vaccine in Ireland, on behalf of the Health Information and Quality Authority (HIQA). A […]
Meningitis B Vaccine – February 2014
Economic Evaluation of a Universal Meningitis B Vaccination Programme in Ireland In February 2014, the National Centre for Pharmacoeconomics completed the evaluation of the cost-effectiveness of a universal meningitis B vaccination programme in Ireland, on behalf of the National Immunisation Advisory Committee (NIAC). A summary of the main findings are […]
Universal Infant Hepatitis B Vaccination programme
Cost effectiveness analysis of a universal infant hepatitis B vaccination programme in Ireland
